2/12
08:14 am
ibio
iBio (NYSE:IBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $5.00 price target on the stock.
Medium
Report
iBio (NYSE:IBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $5.00 price target on the stock.
2/12
08:12 am
ibio
Rating for IBIO
Medium
Report
Rating for IBIO